TB-500 (Thymosin Beta-4 Acetate) is supplied as a peptide-based material for controlled laboratory and analytical research. Because commercial naming conventions for TB-500 and Thymosin Beta-4 vary, accurate scientific identification requires confirmation of the exact peptide sequence, molecular form, acetate association, and lot-specific analytical specifications.
The product should not be assigned generic molecular data solely from its commercial name. Sequence confirmation and authenticated analytical documentation are particularly important for distinguishing short peptide fragments from full-length Thymosin Beta-4 preparations.
Research Applications
The material may be examined in controlled non-clinical research involving:
- Peptide identity and characterization
- Sequence-specific analytical research
- Molecular interaction studies
- Structure-function analysis
- Comparative peptide studies
- Stability assessment
- Chromatographic characterization
- Non-clinical biochemical and cellular models
Any observations should remain specific to the exact peptide preparation being studied and should not be interpreted as evidence of therapeutic, regenerative, recovery-related, or clinical effectiveness.
Structural Information
If the product COA identifies the material as the commonly referenced TB-500 fragment, its sequence may be represented as:
Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln-OH
or:
Ac-LKKTETQ-OH
If the COA instead identifies full-length Thymosin Beta-4, this short sequence should not be used.
The acetate form should also be documented separately from the corresponding free peptide because counter-ion association can alter reported molecular formula and molecular weight.
Analytical Identification
Relevant analytical characterization may include:
- Peptide sequence confirmation
- Molecular mass assessment
- Acetate/counter-ion verification
- Chromatographic purity testing
- Structural characterization
- Peptide identity analysis
- Lot-specific quality testing
Sequence verification is particularly important for this product because commercial nomenclature alone may not establish whether the material is TB-500 fragment or full-length Thymosin Beta-4.
Specifications & Documentation
Lot-specific documentation should be reviewed for:
- Exact peptide identity
- Amino-acid sequence
- Acetate form
- CAS number
- Molecular formula
- Molecular weight
- Purity specification
- Analytical testing
- Lot or batch identification
- Certificate of Analysis
- Storage requirements
The Certificate of Analysis should be treated as the controlling technical source for this product.
Storage & Handling
Store according to the conditions stated on the product label and Certificate of Analysis. Protect the material from environmental conditions that could compromise peptide integrity.
Handling should follow established laboratory procedures appropriate for research materials.
Research Use Only
TB-500 (Thymosin Beta-4 Acetate) is supplied exclusively for laboratory research, analytical testing, and scientific reference purposes.
Disclaimer
For research use only. Not for human or veterinary use. Not intended for consumption, administration, recovery-related use, diagnosis, treatment, mitigation, cure, or prevention of any disease. No therapeutic, regenerative, medical, or clinical claims are made or implied. Product information is supplied solely for scientific identification, documentation, and research reference.





